Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Mechanisms of Development|March 24, 1998
Specific expression in mouse mesoderm- and neural crest-derived tissues of a human PDGFRA promoter/lacZ transgeneX Q Zhang, G B Afink, K Svensson, et al.
The Journal of Biological Chemistry|September 22, 1995
A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptorM L van de Poll, A E Lenferink, M J van Vugt, et al.
Clinical Orthopaedics and Related Research|November 22, 2001
Problems with cementless total knee arthroplasty at 11 years followupR A Berger, J H Lyon, J J Jacobs, et al.
The American Journal of the Medical Sciences|April 16, 2004
Disease-associated qualitative and quantitative trait loci in proteoglycan-induced arthritis and collagen-induced arthritisT T Glant, V A Adarichev, A B Nesterovitch, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1995
The potential role of fibroblasts in periprosthetic osteolysis: fibroblast response to titanium particlesJ Yao, T T Glant, M W Lark, et al.
The Journal of Bone and Joint Surgery. British Volume|July 28, 2004
The combination of pamidronate and calcitriol reverses particle- and TNF-alpha-induced altered functions of bone-marrow-derived stromal cells with osteoblastic phenotypeC Vermes, R Chandrasekaran, J G Dobai, et al.
Biochemical Pharmacology|March 2, 1994
Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cellsS S Wong, R A Sturm, J Michel, et al.
The Bone & Joint Journal|January 7, 2016
Systemic cobalt toxicity from total hip arthroplasties: review of a rare condition Part 1 - history, mechanism, measurements, and pathophysiologyA C Cheung, S Banerjee, J J Cherian, et al.
The Bone & Joint Journal|January 7, 2016
Systemic cobalt toxicity from total hip arthroplasties: review of a rare condition Part 2. measurement, risk factors, and step-wise approach to treatmentM G Zywiel, J J Cherian, S Banerjee, et al.
Nature Genetics|November 4, 2000
Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancersJ J Jacobs, P Keblusek, E Robanus-Maandag, et al.
Pageof 14